Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Researchers say they've discovered the largest known object in the universe, a galactic superstructure called Quipu.
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...
1d
GlobalData on MSNBoehringer seeks approval of lung disease drug after second Phase III successBoehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...
DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...
The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...
DOC, an Italian pharmaceutical company specialized in the marketing of generic drugs, expands its strategy by broadening its business lines and defines a new vision for the future, reflected in a new ...
MicroStrategy Inc. (NASDAQ:MSTR) has officially rebranded as Strategy, reflecting its sharpened focus on Bitcoin ...
Indian food and grocery delivery platform Zomato said on Thursday it will rename the company to "Eternal" and unveiled a new ...
Walmart has already updated its social media accounts to reflect the new logo and wordmark, leading to critical and confused reactions from users. One shared the “before and after” images of ...
However, their new logo and concept have sparked controversy, with some netizens accusing them of plagiarising aespa's aesthetic. NJZ recently introduced their new group name and logo via their ...
Indian food and grocery delivery platform Zomato said on Thursday it will rename the company to "Eternal" and unveiled a new logo, a move that comes more than two years after it began using the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results